Tenet Healthcare Corp (NYSE:THC) – Investigation analysts at Piper Jaffray Organizations decreased their Q2 2019 EPS estimates for shares of Tenet Healthcare in a analysis note issued to investors on Tuesday, April 30th, Zacks Investment Investigation reports. Piper Jaffray Organizations analyst S. James now anticipates that the business will earn $.42 per share for the quarter, down from their preceding estimate of $.63. Piper Jaffray Organizations also issued estimates for Tenet Healthcare’s Q3 2019 earnings at $.52 EPS, FY2019 earnings at $two.43 EPS, Q1 2020 earnings at $.27 EPS, Q2 2020 earnings at $.47 EPS, Q3 2020 earnings at $.42 EPS and FY2020 earnings at $1.91 EPS.
Tenet Healthcare (NYSE:THC) final announced its earnings final results on Monday, April 29th. The business reported $.54 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $.29 by $.25. The business had income of $four.55 billion in the course of the quarter, compared to the consensus estimate of $four.51 billion. Tenet Healthcare had a damaging net margin of .04% and a constructive return on equity of 29.29%. The firm’s income for the quarter was down three.three% on a year-more than-year basis. For the duration of the similar quarter in the prior year, the business posted $.57 earnings per share.
Other analysts also not too long ago issued analysis reports about the stock. Raymond James enhanced their target cost on shares of Tenet Healthcare from $37.00 to $47.00 in a report on Wednesday, February 27th. Citigroup enhanced their target cost on shares of Tenet Healthcare from $35.00 to $37.00 and gave the business a “buy” rating in a report on Wednesday, February 27th. Mizuho restated a “buy” rating and set a $28.00 cost objective on shares of Tenet Healthcare in a report on Monday, January 28th. TheStreet downgraded shares of Tenet Healthcare from a “c” rating to a “d+” rating in a report on Monday, Might 13th. Lastly, Barclays set a $24.00 cost objective on shares of Tenet Healthcare and gave the stock a “hold” rating in a report on Wednesday, April 17th. Two analysis analysts have rated the stock with a sell rating, ten have issued a hold rating and 3 have issued a invest in rating to the business. Tenet Healthcare presently has an typical rating of “Hold” and a consensus cost target of $30.07.
Shares of THC stock opened at $20.84 on Friday. The stock has a market place capitalization of $two.15 billion, a PE ratio of 11.20, a PEG ratio of .38 and a beta of 1.68. The business has a debt-to-equity ratio of 21.98, a present ratio of 1.23 and a swift ratio of 1.15. Tenet Healthcare has a one particular year low of $16.60 and a one particular year higher of $39.74.
Institutional investors and hedge funds have not too long ago purchased and sold shares of the business. Oregon Public Workers Retirement Fund enhanced its stake in shares of Tenet Healthcare by 1,653.four% in the fourth quarter. Oregon Public Workers Retirement Fund now owns 565,569 shares of the company’s stock worth $33,00 following getting an extra 533,313 shares in the final quarter. Enlightenment Investigation LLC bought a new position in shares of Tenet Healthcare in the fourth quarter worth about $36,00. PNC Monetary Solutions Group Inc. enhanced its stake in shares of Tenet Healthcare by 101.9% in the 1st quarter. PNC Monetary Solutions Group Inc. now owns 1,351 shares of the company’s stock worth $38,00 following getting an extra 682 shares in the final quarter. Pearl River Capital LLC bought a new position in shares of Tenet Healthcare in the fourth quarter worth about $41,00. Lastly, Monetary Gravity Wealth Inc. bought a new position in shares of Tenet Healthcare in the 1st quarter worth about $51,00.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare solutions business. The business operates in 3 segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its common hospitals supply acute care solutions, operating and recovery rooms, radiology and respiratory therapy solutions, clinical laboratories, and pharmacies.
Featured Story: Technical Evaluation
Get a absolutely free copy of the Zacks analysis report on Tenet Healthcare (THC)
For far more data about analysis offerings from Zacks Investment Investigation, stop by Zacks.com
Get News & Ratings for Tenet Healthcare Each day – Enter your e mail address under to obtain a concise everyday summary of the most up-to-date news and analysts’ ratings for Tenet Healthcare and connected organizations with MarketBeat.com’s Totally free everyday e mail newsletter.